Profile
Dr. Mamata Gokhale is a Senior Vice President-Regulatory Affairs at CytomX Therapeutics, Inc. Dr. Gokhale was previously employed as a Vice President-Regulatory Affairs by Perspective Therapeutics, Inc. and a Vice President & Global Head-Regulatory Affairs by Actinium Pharmaceuticals, Inc. She received her undergraduate degree from the University of Pune, a graduate degree from the University of Pune and a doctorate degree from the University of Mumbai.
Mamata Gokhale active positions
| Companies | Position | Start |
|---|---|---|
| CYTOMX THERAPEUTICS, INC. | General Counsel | 17/05/2026 |
Former positions of Mamata Gokhale
| Companies | Position | End |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | General Counsel | 31/12/2020 |
| PERSPECTIVE THERAPEUTICS, INC. | General Counsel | - |
Training of Mamata Gokhale
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
University of Mumbai
University of Mumbai Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Pune
University of Pune Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
CytomX Therapeutics, Inc.
CytomX Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as an oncology-base biopharmaceutical company, which focuses on developing probody therapeutics for the treatment of cancer | Health Technology |
Perspective Therapeutics, Inc.
Perspective Therapeutics, Inc. Medical SpecialtiesHealth Technology Develops medical technology devices | Health Technology |
- Stock Market
- Insiders
- Mamata Gokhale
















